Telemedicine in the Era of COVID-19: Mitigating Risk for People Living with Multiple Sclerosis

RELEASE DATE: July 31, 2020 EXPIRATION DATE: July 31, 2021 Credit Available Physicians — maximum of 1.5 AMA PRA Category 1 Credit(s) Nurses — 1.5 Contact Hours Pharmacists – 1.5 Contact Hours All other health care professionals completing this course will be issued a statement of participation. Target Audience This activity is intended for neurology and primary care […]

The New Era of Neuromyelitis Optica Spectrum Disorder: Advances in Diagnosis and Treatment

RELEASE DATE: July 31, 2020 EXPIRATION DATE: July 31, 2021 Credit Available Physicians— maximum of 1.25 AMA PRA Category 1 Credit(s)™ Nurses— 1.25 Nursing Contact Hours Pharmacists— 1.25 Contact Hours (0.125 CEUs) All other healthcare professionals completing this course will be issued a statement of participation. Target Audience The target learning audience for this initiative is […]

Precision Medicine with Polypharmacy in Multiple Sclerosis: What does it mean in practice?

RELEASE DATE: July 15, 2020 EXPIRATION DATE: September 14, 2021 Precision Medicine with Polypharmacy in Multiple Sclerosis: What does it mean in practice? Jointly provided by Consortium of Multiple Sclerosis Centers and PlatformQ Health Education, LLC Credit Available Physicians— maximum of 1 AMA PRA Category 1 Credit(s)™ Nurses— 1 Nursing Contact Hours Pharmacists— 1 Contact Hours (0.1 CEUs) […]

Novel BTK Inhibitors: Effects on Adaptive and Innate Immunity in Multiple Sclerosis

RELEASE DATE: July 1, 2020 EXPIRATION DATE: June 30, 2021 Program Overview This CME/CE program will highlight novel BTK (Bruton’s tyrosine kinase) inhibitors and their effects on adaptive and innate immunity in multiple sclerosis (MS). The expert faculty, led by Dr. Fred D. Lublin, will review BTK inhibitor science as a therapeutic target to reduce […]

Everything You’ve Wanted to Know About MS But Were Afraid to Ask

RELEASE DATE: June 30, 2020 EXPIRATION DATE: June 30, 2021 This series of videos is a comprehensive online curriculum that provides evidence-based, expert-directed overviews of topics related to the multidisciplinary management of multiple sclerosis (MS). Our expert faculty share their knowledge and insights with the goal of improving application of the latest evidence related to […]

Journal Club: The COVID-19 Pandemic and the Use of MS Disease Modifying Therapies

Release Date: July 8, 2020 Valid for Credit Through: July 31, 2021 SERIES TITLE Advanced Perspectives in MS: A Virtual Journal Club Series for the Multiple Sclerosis Clinician ARTICLE TITLE The COVID-19 Pandemic and the Use of MS Disease Modifying Therapies TARGET AUDIENCE This activity has been designed to meet the educational needs of physicians, […]

A Virtual Reality View: Selecting Disease-Modifying Therapy for Multiple Sclerosis: Tools to Achieve and Maintain Control of a Dynamic Disease

RELEASE DATE: June 16, 2020 EXPIRATION DATE: June 16, 2021 FACULTY Patricia K. Coyle, MD, FAAN, FANA Professor and Interim Chair Director, MS Comprehensive Care Center Stony Brook University Medical Center Stony Brook, New York PROGRAM OVERVIEW This activity will cover the treatment and management of patients with multiple sclerosis (MS). TARGET AUDIENCE This activity is designed […]

The Role of Neurologists and Neuroophthalmologists in the Diagnosis and Management of Neuromyelitis Optica Spectrum Disorder

RELEASE DATE: June 16, 2020 EXPIRATION DATE: June 16, 2021 FACULTY Brian G. Weinshenker, MD, FRCP(C) Consultant, Department of Neurology Professor of Neurology, College of Medicine Mayo Clinic Rochester, MN PROGRAM OVERVIEW This case-based activity will cover the treatment and management of patients with NMOSD. TARGET AUDIENCE This activity is designed to meet the educational needs of […]

The Iceberg Effect: Subclinical Disease Activity in Multiple Sclerosis

RELEASE DATE: June 1, 2020 EXPIRATION DATE: June 1, 2021 TARGET AUDIENCE This activity is designed to meet the educational needs of physicians, nurses, advanced practice clinicians, and pharmacists who manage patients with multiple sclerosis (MS). PROGRAM DESCRIPTION Asymptomatic or subclinical progression occurs in all stages of multiple sclerosis (MS) and should be part of treatment decisions, […]

Right Patient, Right Treatment, Right Time: Utilizing Early, High-Efficacy Therapies to Improve Outcomes in RRMS

RELEASE DATE: June 8, 2020 EXPIRATION DATE: June 8, 2021 THIS ACTIVITY OFFERS CE CREDIT FOR: Physicians (CME) Nurses (CNE) Pharmacists (ACPE) ABIM (MOC) Other All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™ FACULTY Fred D. Lublin, MD, FAAN, FANA Saunders Family Professor of […]